Close

Breast Cancer

Open
  • Results are currently sorted by relevance (Sort results by:  date)
  • Results 1 - 10 (of 42345)
  • 
  • Accredited source

    CG81 Advanced breast cancer: full guideline

    ...on advanced breast cancers provides a good...advanced breast cancer, or the outcome...6 drugs for cancers that included breast cancer, and for trastuzumab...HER2 negative cancers may receive...with advanced breast cancer, there will...

    National Institute for Health and Care Excellence, 03 March 2009 - Publisher: NICE - Publication type: Full Guidance

  • Accredited source

    CG80 Early and locally advanced breast cancer: full guideline

    ...local recurrence for breast conserving surgery...patients eligible for breast conserving surgery...invasive lobular cancers (Deurloo et al...those with dense breasts on mammography...In non-fatty breasts ultrasound and MRI...mammography for invasive cancer, but both MRI and...occult invasive breast cancers with the sensitivity...

    National Institute for Health and Care Excellence, 03 March 2009 - Publisher: NICE - Publication type: Full Guidance

  • Accredited source

    CG164 Familial breast cancer: full guideline

    ...at familial cancers in general...than familial breast cancer in particular...negative” breast cancers (oestrogen...onset breast cancer in a small...e. both breasts or both ovaries...Bilateral breast cancer Cancer that...

    National Institute for Health and Care Excellence, 25 June 2013 - Publisher: NICE - Publication type: Full Guidance

  • Accredited source

    CG164 Familial breast cancer: NICE guidance

    ...tumours  multiple cancers (including bilateral...personal history of breast cancer presents with breast...following female breast cancers only in the family...diagnosed with breast cancer at younger than an...2013 Familial breast cancer NICE clinical guideline...group with dense breasts and the increased...

    National Institute for Health and Care Excellence, 25 June 2013 - Publisher: NICE - Publication type: NICE Guidance

  • Accredited source

    DG10 Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat: guidance

    ...decisions in early breast cancer management...chemotherapy in breast cancer by more accurately...biological features of cancers may indicate an...return of detectable cancer in another part...groups. The specific cancers in the low-risk...the management of breast cancer and the proportion...

    National Institute for Health and Care Excellence, 25 September 2013

  • Accredited source

    CG80 Early and locally advanced breast cancer: NICE guideline

    ...of all invasive breast cancers, using...patients with invasive breast cancer. 1.6.3 Test...invasive breast cancers, using a standardised...advanced breast cancer NICE clinical guideline...invasive breast cancer and a high risk...with early invasive breast cancer, inform...women with larger breasts. Radiotherapy...

    National Institute for Health and Care Excellence, 25 February 2009 - Publisher: NICE - Publication type: NICE Guidance

  • Accredited source

    CG81 Advanced breast cancer: NICE guideline

    Advanced breast cancer Diagnosis and treatment Issued...treatment of locally advanced or metastatic breast cancer' (NICE technology appraisal guidance... 'Taxanes for the treatment of breast cancer' (NICE technology appraisal guidance...

    National Institute for Health and Care Excellence, 25 February 2009 - Publisher: NICE - Publication type: NICE Guidance

  • Accredited source

    TA295 Breast cancer (HER2 negative, oestrogen receptor positive, locally advanced or metastatic) - everolimus (with an aromatase inhibitor): guidance

    ...hormone-receptorpositive breast cancer after endocrine therapy...hormone-receptorpositive breast cancer after endocrine treatment...studies' (of other cancers). In revised modelling...progression' in metastatic breast cancer using the standard gamble...

    National Institute for Health and Care Excellence, 28 August 2013 - Publisher: NICE - Publication type: Full Guidance

  • Accredited source

    TA257 Breast cancer (metastatic hormone-receptor) - lapatinib and trastuzumab (with aromatase inhibitor): guidance

    ...present with metastatic breast cancer, and approximately...later develop metastatic breast cancer. Common sites...When clinicians manage breast cancer they consider...and 80% of all breast cancers in premenopausal and...hormonereceptor-positive breast cancer generally have a better...

    National Institute for Health and Care Excellence, 27 June 2012 - Publisher: NICE - Publication type: Full Guidance

  • Accredited source

    TA263 Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer: guidance

    ...treatment of metastatic breast cancer fulfilled the criteria...small-cell lung cancers. Therefore, it does...treatment of metastatic breast cancer NICE technology appraisal...Page 38 of 48 breast cancer fulfilled the criteria...nonsmall-cell lung cancers. Therefore, it does...

    National Institute for Health and Care Excellence, 22 August 2012 - Publisher: NICE - Publication type: Full Guidance

Results 1 - 10 (of 42345)
loading